AstraZeneca and Abbott end license agreement for the development of Certriad
3 January 2011 | By AstraZeneca
AstraZeneca has notified Abbott that it will discontinue the development of CERTRIAD on 22 January 2011...
List view / Grid view
News
ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO
21 December 2010 | By The Scott Partnership
ERT, today confirmed that the effective date of the previously announced retirement of Dr. Michael J. McKelvey, its President and CEO, is December 21, 2010...
PharmaNet Offers Guidance on Regulatory Pathway for Biosimilars Development Following Recent FDA Hearing
20 December 2010 | By The Scott Partnership
PharmaNet, are available to offer guidance on the regulatory pathway for biosimilar development...
Proximagen acquires two CNS drug development programmes from GlaxoSmithKline
20 December 2010 | By M:Communications
Proximagen, has signed an exclusive agreement with GSK to acquire the global rights to two drug development programmes...
The Scott Partnership to Present Short Course on Marketing in Asia Pacific at Pittcon 2011
16 December 2010 | By The Scott Partnership
The Scott Partnership, has been selected by the organisers of Pittcon 2011 to deliver a short-course entitled ‘Marketing in Asia Pacific...
ERT Unveils Full Range of ePRO Solutions Providing the Power of Choice for Clinical Trial Sponsors
16 December 2010 | By The Scott Partnership
ERT, today announced the launch of its comprehensive suite of electronic patient-reported outcome (ePRO) solutions...
Sigma® Life Science Creates World’s First Knock-in Rats using Zinc Finger Nuclease Technology
13 December 2010 | By Sigma Life Science
Sigma Life Science, announced that its SAGE Labs initiative has successfully used its proprietary CompoZr® ZFN technology...
Infinite® 200 PRO offers environmental control for cell-based applications
9 December 2010 | By kdm communications limited
Tecan has launched a Gas Control Module (GCM™) for its Infinite 200 PRO multimode microplate reader...
Zealand Pharma Receives Milestone Payment from Helsinn Healthcare
9 December 2010 | By M:Communications
Zealand Pharma, today announces the receipt of a EUR 500,000 milestone payment as part of its license agreement with Helsinn Healthcare...
Point-of-care cardiac assays shorten turnaround times in emergency departments
8 December 2010 | By kdm communications limited
Radiometer, has used its expertise in acute clinical testing to develop a compact and cost-effective immunoassay analyser for measuring critical biomarkers at the patient’s bedside.
ERT Facilitates Global Growth with Appointment of Klaus Besier to Board of Directors
8 December 2010 | By The Scott Partnership
ERT, announced the appointment of Klaus Besier to the Company’s Board of Directors...
bioMérieux’s BioBall® Mixed Kits Provide Flexibility for the Pharmaceutical Industry
7 December 2010 | By bioMérieux
BioBall® is a small water soluble ball containing a precise number of micro-organisms delivering unprecedented accuracy...
European Commission Approves Brilique™ (Ticagrelor Tablets)
6 December 2010 | By AstraZeneca
AstraZeneca announced today that the European Commission has granted marketing authorisation to BRILIQUE™ (ticagrelor tablets)...
Phase II study with first-in-class investigational drug demonstrates improvement in negative symptoms in patients with schizophrenia
6 December 2010 | By F. Hoffmann-La Roche Ltd
Roche today presented eight-week results from a phase II study of RG16781...
e-Therapeutics plc Board appoints Stephen Self to direct development
6 December 2010 | By M:Communications
e-Therapeutics plc, announced that Steve Self, Development Director, has agreed to join the Board as an Executive Director with immediate effect...
